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A cluster randomized trial comparing 
deltamethrin and bendiocarb as insecticides 
for indoor residual spraying to control malaria 
on Bioko Island, Equatorial Guinea
John Bradley1* , Dianna Hergott2, Guillermo Garcia2, Jo Lines3, Jackie Cook1, Michel A. Slotman4, 
Wonder Philip Phiri2, Christopher Schwabe2 and Immo Kleinschmidt1,5
Abstract 
Background: Indoor residual spraying (IRS) has been used on Bioko for malaria control since 2004. In 2013 the 
insecticide was changed from bendiocarb to deltamethrin. Shortly after this change, there was a marked increase in 
malaria prevalence on the island. This trial was carried out to compare the effectiveness of bendiocarb and deltame-
thrin for use in IRS on Bioko.
Methods: Twenty-four clusters of houses were randomized to receive IRS with either bendiocarb or deltamethrin. 
Approximately 3 months after the intervention, the prevalence of malaria and levels of haemoglobin were measured 
in children aged 2–14 years in each cluster.
Results: Prevalence of malaria in 2–14 year olds was lower in the bendiocarb arm (16.8, 95 % CI 11.1–24.7, N = 1374) 
than in the deltamethrin arm (23.2, 95 % CI 16.0–32.3, N = 1330) but this difference was not significant (p = 0.390), 
even after adjusting for covariates (p = 0.119). Mean haemoglobin in children was marginally higher in the bendio-
carb clusters (11.6 g/dl, 95 % CI 11.5–11.8, N = 1326) than in the deltamethrin clusters (11.5 g/dl, 95 % CI 11.3–11.7, 
N = 1329). This difference was borderline significant after adjusting for covariates (p = 0.049).
Conclusions: The results are suggestive of bendiocarb being more effective at preventing malaria on Bioko although 
evidence for this was weak. The results are likely due to the fact that local vectors remain fully susceptible to bendio-
carb whereas subsequent tests have shown resistance to deltamethrin.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Indoor residual spraying (IRS)—spraying the interior 
walls of houses with insecticide—is a highly effective 
form of vector control with a long history in malaria pre-
vention [1]. It was the mainstay of the Global Malaria 
Eradication Program launched by the World Health 
Organization (WHO) in 1955, responsible for eliminat-
ing malaria from large parts of the world [2]. IRS is used 
extensively: in 2014, 50 million people in sub-Saharan 
Africa were protected by IRS, representing 6  % of the 
population at risk in the region [3].
Bioko Island has had a historically high malaria burden. 
To combat this, the Bioko Island Malaria Control Project 
(BIMCP) was launched in 2004 [4]. The Project has had 
considerable success in reducing malaria prevalence and 
child mortality [5, 6]; and much of this success has been 
attributed IRS [7].
The first IRS round on the island took place in 2004 
using the insecticide deltamethrin. Deltamethrin IRS 
was discontinued after one spray round as a precaution 
because the kdr mutation was detected at high frequency 
in Anopheles gambiae s.s. [4]. IRS with the insecticide 
bendiocarb was introduced in 2005 to maintain the 
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effectiveness of IRS and reduce selection pressure for 
resistance to pyrethroids [4]. Bendiocarb was sprayed 
biannually on Bioko until 2013, when policy changed to 
one spray round a year with a long lasting formulation of 
deltamethrin. The decision to change was taken for sev-
eral reasons: (1) detailed analysis of pyrethroid resistance 
in An. gambiae on Bioko in 2011 showed no evidence 
that P450-based metabolic resistance mechanisms were 
present [8]; (2) re-analysis of data from 2004 indicated 
that deltamethrin in fact was effective at controlling local 
vectors [8]; (3) rotation of insecticides is recommended 
by the WHO to manage insecticide resistance [9]; (4) 
bendiocarb has a short residual life and had been shown 
to leave the population unprotected for parts of the year 
[10, 11] and (5) the new long acting formulation of del-
tamethrin required only one spray round a year, reducing 
the cost.
After the first spray round with the new deltamethrin 
formulation in 2013, malaria infection prevalence in 
2–14  year old children, measured annually in an island 
wide cross-sectional malaria indicator survey, rose from 
14  % in 2012 to 28  % in the following year. This sharp 
rise in prevalence prompted the BIMCP to carry out the 
trial reported here to compare the effectiveness of del-
tamethrin and bendiocarb as an IRS insecticide on Bioko 
Island.
Methods
Study setting
Bioko Island is part of Equatorial Guinea. It has an area of 
approximately 2000 km2 and lies 32 kms off the coast of 
Cameroon in Central Africa. The population is approxi-
mately 250,000, with the majority of people living in 
Malabo, the island’s major city. A malaria indicator sur-
vey in 2004, before the start of island wide IRS, found a 
parasite prevalence of 46  % in children aged from 2 to 
14 years [6]. IRS has been the predominant form of vec-
tor control used by the BIMCP, but in addition there was 
a single mass distribution of long-lasting insecticidal nets 
(LLINs) in 2008, and continuous distribution of LLINs 
to pregnant women as part of antenatal care. High cov-
erage of LLINs has not been maintained: only 13  % of 
2–14 year old children reported sleeping under a LLIN in 
2013 (BIMCP, unpublished observations).
The most important malaria vectors on Bioko are An. 
gambiae s.s. throughout the island, and Anopheles melas 
in coastal areas [12–14]. The BIMCP measures entomo-
logical indicators at ten sentinel sites throughout the 
island. This includes monitoring the susceptibility of local 
mosquitoes to insecticides used in malaria control [8] 
using the standard WHO test [15]. In 2014, 24-h mor-
tality of local An. gambiae s.s was 100 % (N = 80) after 
exposure to bendiocarb and 79.6 % (N = 240) after expo-
sure to deltamethrin (BIMCP unpublished observations). 
Deltamethrin continued to be used by BIMCP as part of 
a planned long-term insecticide rotational scheme and 
because tests had shown metabolic resistance not to be 
present on the island [8].
Trial design
Clusters of households were randomized to two trial 
arms, one receiving bendiocarb IRS, the other receiving 
deltamethrin IRS (Fig.  1). These clusters were formed 
using the BIMCP mapping system which has divided the 
island up into 100  m2 sectors to facilitate routine IRS. 
Clusters constituted groups of adjacent sectors to make 
up at a minimum of 250 households whilst ensuring a 
distance of at least 300 m between the borders of adjacent 
clusters (Fig. 2). Neighbourhoods known to have a high 
rate of refusing IRS in the past were not eligible for par-
ticipation in the trial. Eighteen clusters in urban Malabo 
were selected, along with six clusters in rural locations.
The primary comparison between the arms was the 
prevalence of Plasmodium falciparum malaria in chil-
dren aged from 2 to 14  years. Two secondary compari-
sons were made: mean haemoglobin on the same set of 
Clusters identified (n= 24)
Baseline survey of 955 
households and 1799 
children aged 2 to 14.
Randomised (n = 24)
Allocated to and 
received Bendiocarb IRS
(n = 12)
Allocated to and 
received Deltamethrin 
IRS (n = 12)
Endline survey (n= 12)
507 households 
surveyed
1374 children aged 2 to 
14 tested for parsitemia 
by RDT
Endline survey (n= 12)
508 households 
surveyed
1330 children aged 2 to 
14 tested for parsitemia 
by RDT
Fig. 1 Overview of trial
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children; and the proportion of households willing to 
have their house sprayed with the insecticide in future 
spray rounds.
Sample size calculations were made assuming a mean 
prevalence of P. falciparum of 28 % in the deltamethrin 
arm and 14 % in the bendiocarb arm. These prevalences 
are the estimated island wide prevalences in 2013 and 
2012 when deltamethrin and bendiocarb were used for 
IRS respectively. The coefficient of variation between 
clusters was assumed to be 0.25—this is suggested in the 
methodological literature as a reasonable value to assume 
in the absence of data [16]. Under these assumptions, 
with 12 clusters in each arm and 120 children recruited 
for the survey in each cluster, the trial had over 90  % 
power to detect a difference in prevalence between the 
arms at the 5 % significance level.
Restricted randomization was used to achieve balance 
between the arms on variables expected to be predictive 
of malaria outcomes [17]. Data on these variables was 
collected in a cross sectional baseline survey of 40 ran-
domly selected households per cluster in March 2014. 
The restrictions were: each arm had to have three of the 
six rural clusters, and the mean of the following variables 
could not differ by more than 10  % between trial arms: 
the baseline prevalence of malaria in children aged from 
2 to 14  years measured by rapid diagnostic test (RDT) 
(Carestart, Access-Bio Inc., Monmouth, USA); the pro-
portion of households with at least one LLIN per two 
people; the proportion of households wanting IRS; and 
the proportion of houses that received IRS in the last 
spray round.
Two hundred thousand allocations were generated at 
random, 6304 of which satisfied the imposed restrictions. 
After checking that these 6304 randomizations allowed 
independence of allocation between pairs of clusters, one 
of the eligible allocations was chosen at random.
Interventions
The intervention took place in March and April 2014. 
All households in the trial were offered IRS according 
to the study arm they had been allocated to. The two 
insecticides were bendiocarb (Ficam™, Bayer) in the 
insecticide class of carbamates, and a long lasting formu-
lation of deltamethrin (K-Othrine™, Bayer) in the class 
of pyrethroids. Both insecticides are approved for pub-
lic health use by the WHO Pesticide Evaluation Scheme 
(WHOPES) [18, 19]. Spraying was done at the WHOPES 
recommended dose (0.02–0.025 and 0.1–0.4  g of active 
ingredient per square metre for deltamethrin and ben-
diocarb, respectively). Bendiocarb has a residual life 
of 2–6 months and deltamethrin has a residual life of 6 
months [18]. Spray teams aimed to spray at least 85  % 
of households in each cluster. If less than 85 % of house-
holds were sprayed on the first visit, the spray teams 
made further visits to the cluster until either 85  % cov-
erage had been reached or the team had returned three 
times. It was explained to households that they had the 
right to refuse IRS.
Each cluster was surrounded by a buffer zone of 300 m 
in which houses were sprayed with the same insecticide 
as the houses in the cluster. In cases where the distance 
between two clusters was less than 600 m, the buffer zone 
extended to half way between the clusters (Fig. 2).
Evaluation
The effect of the interventions was evaluated by a cross 
sectional household survey in June and July 2014, 
11–13  weeks after spraying. The evaluation was timed 
to precede expiry of the residual life of both insecticides. 
Databases of households used by the BIMCP in the rou-
tine IRS programme were used to obtain a random sam-
ple of 60 households per cluster. Surveyors visited each 
selected household and, if any children aged 2–14 years 
were present, sought written informed consent from 
the caregiver/householder to take part in the trial. At 
each participating household three children aged from 
2–14  years were randomly selected (or all children if 
there were three or fewer present) and were tested for 
parasitaemia by RDT (Carestart, Access-Bio Inc., Mon-
mouth, USA) and had their haemoglobin measured 
(HemoCue, Ängelholm, Sweden). An adult was asked 
whether their house was sprayed, if they liked the insec-
ticide they received and whether they would accept it 
again in the next spray round. They were also asked about 
ownership and use of bed nets. The endline survey took 
place only in the core area of each cluster, not in the 
buffer zone.
Statistical analysis
Parasitaemia, spray coverage and acceptability of IRS 
were analysed as binary outcomes using logistic regres-
sion. Generalized estimating equations with exchange-
able working correlation matrix and robust standard 
errors were used to account for intra cluster correlation 
of responses. Haemoglobin level was analysed as a con-
tinuous outcome using linear regression with a cluster 
level random intercept to account for intra cluster cor-
relation. All analyses were carried out as intention to 
treat, so that all clusters were included regardless of the 
level of coverage received. Analyses adjusting for baseline 
malaria prevalence, sleeping under a bed net the night 
before the survey, reported IRS coverage, age, and rural 
vs urban location were carried out as secondary analysis. 
All analyses were done using Stata version 13 [20].
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Ethics approval
Ethics approval for the trial was granted by the Equatorial 
Guinea Ministry of Health and Social Welfare and the eth-
ics committee of the London School of Hygiene and Trop-
ical Medicine (approval number 8048). Written informed 
consent was obtained from all participants. In both the 
baseline and endline surveys, children testing positive for 
malaria were given standard first line anti-malarial treat-
ment according to national policy (Artemisinin plus amo-
diaquine) from a trial nurse. Children with anaemia were 
referred to a local health facility for further treatment.
Results
Baseline
In the baseline survey, 955 households were surveyed and 
1799 children were tested for malaria. Baseline characteris-
tics were similar between the two trial arms (Table 1). Base-
line prevalence in the bendiocarb arm was 17.5 % (95 % CI 
12.3–24.3) compared with 18.4  % (95  % CI 12.7–25.9) in 
the deltamethrin arm. The range of baseline prevalences 
by cluster was 2.0–41.6 %. There were similar proportions 
of houses receiving IRS in the bendiocarb and deltamethrin 
arms (85.0 vs 83.5 % respectively); willing to accept IRS (89.2 
vs 91.4 %); owning as least one net (64.1 vs 66.8 %); and hav-
ing at least one net for every two persons (26.7 vs 25.0 %).
Parasitaemia and haemoglobin post‑intervention
In the endline survey, 1015 households were visited; 2704 
children were tested for parasitaemia; and 2655 haemo-
globin measurements were recorded (Table 1). Prevalence 
of malaria in 2–14 year olds was lower in the bendiocarb 
arm (16.8, 95 % CI 11.1–24.7, N = 1374) than in the del-
tamethrin arm (23.2, 95 % CI 16.0–32.3, N = 1330) but 
this difference was not significant (p = 0.390), even after 
adjusting for covariates (p = 0.119) (Table 2). There was 
substantial variability in endline malaria prevalence: the 
range in the bendiocarb clusters and deltamethrin clus-
ters was 1.6–40.9, and 1.3–50.8  % respectively. Mean 
haemoglobin was marginally higher in the bendiocarb 
clusters (11.6 g/dl, 95 % CI 11.5–11.8, N = 1326) than in 
the deltamethrin clusters (11.5  g/dl, 95  % CI 11.3–11.7, 
N  =  1329), with very weak evidence for a difference 
Fig. 2 The trial clusters in Central Malabo. The shaded area around the cluster represents the buffer zone. Pink clusters were sprayed with deltame-
thrin and blue clusters with bendiocarb
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(p = 0.302). After adjusting for covariates, the difference 
in haemoglobin between study arms was borderline sig-
nificant (p = 0.049).
Coverage
Mean reported IRS coverage was 73.7 % (95 % CI 67.1–
79.4, N = 495) in the bendiocarb arm and 76.5 % (95 % CI 
71.6–80.9, N =  490) in the deltamethrin arm. Reported 
coverage ranged from 50.0 to 84.9  % in the bendiocarb 
clusters and from 64.7 to 100.0  % in the deltamethrin 
clusters. The difference in coverage between the arms 
was not significant (p = 0.368).
Acceptability
In response to the question Did you like the insecti-
cide that was used to spray your house? 85.1 % (95 % CI 
80.4–88.8, N = 295) of households that received bendi-
ocarb said yes, compared to 85.3 % (95 % CI 79.5–89.7, 
N  =  292) of households that received deltamethrin 
(p = 0.959).
In response to the question If the same insecticide is 
used in the next round, would you accept to have your 
house sprayed? 92.8  % (95  % CI 89.3–95.2, N =  304) of 
households that received bendiocarb said yes, compared 
to 92.5  % (95  % CI 88.8–95.1, N  =  310) of households 
that received deltamethrin (p = 0.933).
Use of bed nets
In the bendiocarb arm, 30.1  % (95  % CI 20.8–41.3) of 
2–14  year old children slept under aLLIN the night 
before the survey, compared to 31.7  % (95  % CI 18.9–
48.1) in the deltamethrin arm (p = 0.368).
Table 1 Baseline variables for the 24 trial clusters
Bendiocarb arm Deltamethrin arm Total
Malaria prevalence in children aged 2–14 years,  
measured by RDT
 % [95 % CI] (N) 17.5 [12.3–24.3] (845) 18.4 [12.7–25.9] (954) 18.0 [14.0–22.8] (1799)
 Range,  % 5.3–38.9 2.0–41.6 2.0–41.6
Houses reporting receiving IRS in the last year
 % [95 % CI] (N) 85.0 [79.9–89.0] (340) 83.5 [75.4–89.2] (387) 84.2 [79.6–87.9] (727)
 Range,  % 64.7–100 63.7–100 63.7–100
Households willing to accept IRS
 % [95 % CI] (N) 89.2 [86.1–91.2] (406) 91.4 [86.7–94.6] (466) 90.4 [87.6–92.5] (872)
 Range,  % 78.6–96.7 72.4–100 72.4–100
Households owning at least one net
 % [95 % CI] (N) 64.1 [50.0–76.2] (379) 66.8 [57.3–75.1] (425) 65.6 [57.4–72.9] (804)
 Range,  % 24.2–90.5 50.0–96.7 24.2–96.7
Households with at least one net per 2 people
 % [95 % CI] (N) 26.7 [18.5–36.9] (378) 25.0 [16.9–35.2] (424) 25.8 [19.9–32.7] (802)
 Range,  % 9.5–53.4 6.3–66.7 6.3–66.7
Table 2 Outcome measures at endline
a Adjusted for baseline malaria prevalence, sleeping under a bet the night before the survey, reported IRS coverage, age and rural vs urban location
Bendiocarb arm Deltamethrin arm
Malaria prevalence in children aged 2–14 years,  
measured by RDT
 % [95 % CI] (N) 16.8 [11.1–24.7] (1374) 23.2 [16.0–32.3] (1330)
 Range,  % 1.6–40.9 1.3–50.8
 OR [95 % CI] – 1.33 [0.70–2.54] p = 0.390
 Adjusteda OR [95 % CI] – 1.50 [0.86–2.64] p = 0.154
Haemoglobin, g/dl
 Mean [95 % CI] (N) 11.63 [11.46–11.80] (1326) 11.50 [11.33–11.67] (1329)
 Range,  % 11.08–11.98 10.80–12.07
 Difference [95 % CI] – 0.13 [0.11–0.37] p = 0.302
 Adjusteda difference [95 % CI] – 0.13 [0.00–0.27] p = 0.049
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Discussion
The aim of this trial was to compare the effectiveness of 
deltamethrin and bendiocarb as an IRS insecticide on 
Bioko Island—and in particular to determine if the rise 
in malaria prevalence on Bioko in 2013 could be attrib-
uted to changing from bendiocarb to deltamethrin IRS. 
The results are inconclusive. The prevalence of malaria in 
children was markedly lower in bendiocarb clusters than 
in deltamethrin clusters-but this was not statistically sig-
nificant so the difference could be due to chance. The evi-
dence for a difference in haemoglobin was stronger-but 
only after adjusting for confounders, and the difference 
was too small to be clinically significant.
There are several aspects of the trial design and imple-
mentation that could have contributed to a non-signifi-
cant result. In a cluster randomized trial of an infectious 
disease it is important that clusters be big enough to cap-
ture mass effects of an intervention: in this trial it would 
be the benefit derived from surrounding houses receiving 
IRS, whether or not your own house was sprayed. It is also 
important that clusters are sufficiently far apart to avoid 
spillover effects: in this case residents of a cluster ben-
efiting from vector suppression in a neighbouring cluster 
[21]. In an ideal world clusters should be as large as possi-
ble and as far away from each other as possible, but in the 
real world this must be balanced against logistic, financial 
and geographical constraints. In this trial, clusters com-
prised at least 250 houses and the border of each cluster 
was at least 300 m from the border of another cluster. It 
is not known how big or far apart clusters have to be in 
a trial of vector control for malaria prevention; but there 
is some evidence that spill-over effects of vector control 
interventions may be restricted to approximately 300  m 
[22]. It is possible that if the trial had used bigger clusters 
which were further apart, then a statistically significant 
result may have been obtained. In addition, households 
which were not in a cluster area were sprayed with the 
long-lasting deltamethrin product during the spray round, 
possibly diluting the effect of bendiocarb. Logistical con-
straints prevented a trial with larger separation between 
clusters from being implemented.
The power of the trial is affected by the amount of inter 
cluster variation in the primary outcome: the higher the 
variation, the lower the power. Since there were no data 
on variation of cluster level malaria prevalence, a coef-
ficient of variation of 0.25 was assumed for sample size 
calculations; as suggested in the methodological litera-
ture [16]. However, baseline cluster level malaria preva-
lence in 2–14  year olds ranged from 2.0 to 41.6  %, and 
the estimated coefficient of variation was 0.59. If the sam-
ple size calculation is repeated with a coefficient of vari-
ation equal to 0.59 rather than 0.25, then power is only 
68 %. The large inter cluster variation could be a reason 
that the trial did not find a statistically significant result. 
In the light of the high variation in baseline prevalence, it 
may have been wise to consider matching or stratification 
as ways of increasing the trial power [16].
In this trial only 24 clusters were randomized and 
this may not have been enough to achieve balance on 
all confounding factors. Although efforts were made to 
minimize bias through restricted randomization and 
regression adjustments, there may be some residual bias 
due to unmeasured confounders. For example, house 
construction [23] and prevalence of travel to the main-
land [24] have both been shown to be important risk 
factors for malaria infection on Bioko but were not meas-
ured at either baseline or endline.
The trial took place over a short period of time. IRS can 
have a rapid effect on malaria transmission [1], but it is 
possible that in this case 3 months was not long enough 
to have an effect on malaria infection prevalence, even if 
there was a difference in effectiveness between the two 
insecticides. It would have been instructive to have ento-
mological endpoints such as mosquito parity or entomo-
logical inoculation rate as secondary outcome measures, 
because IRS may affect these measures over a shorter 
time period. Unfortunately, this was not possible due 
to logistical constraints. Conversely, since bendiocarb 
has been shown to wane in effectiveness 3 months after 
spraying [10], it is also possible that a smaller difference 
between the trial arms would have been detected had the 
trial taken place over a longer period.
The WHO recommends that IRS coverage be at least 
80  % to be optimally effective [3] which has been con-
firmed by previous studies in Bioko [25]. Reported cov-
erage in this trial was 73.7–76.5  % in the bendiocarb 
and deltamethrin arms, respectively, which could have 
reduced the effectiveness of IRS in both arms and less-
ened the difference between them.
The results of this study have to be interpreted in the 
particular context of Bioko rather than simply as the 
effectiveness of the two insecticides per se. Resistance of 
Anopheles mosquitoes to insecticides is widely seen as 
a threat to malaria control in Africa [26, 27]—and there 
have been persistent concerns of resistance of local vec-
tors to deltamethrin. Over the course of the BIMCP, the 
insecticide used for IRS has been switched twice. In 2005, 
the IRS insecticide was changed to bendiocarb after the 
first round of deltamethrin spraying in 2004, because a 
large proportion of An. gambiae s.s. caught in window 
exit traps had the kdr mutation—indicative of pyrethroid 
resistance [4]. Bendiocarb was subsequently sprayed 
twice a year until 2012, during which time malaria preva-
lence declined substantially [23].
Although vectors were shown to remain susceptible to 
bendiocarb, and PCR analysis showed that the proportion 
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of An. gambiae s.s. with the kdr mutation remained high-
the BIMCP reverted to deltamethrin as its IRS insec-
ticide in 2013. This switch was prompted by a number 
of factors: (1) reanalysis of samples and data from 2004 
showed that post-spraying with deltamethrin, An. gam-
biae s.s. mosquitoes with the kdr mutation did not have 
a higher sporozoite rate than those without the mutation 
and that IRS with deltamethrin had significantly reduced 
the abundance of An. gambiae s.s. [8]; (2) An. gambiae 
s.s. collected in 2011 showed no evidence of metabolic 
resistance to deltamethrin [8]; and (3) annual IRS with 
long-lasting deltamethrin was considerably less costly 
than biannual IRS with bendiocarb. However, WHO bio-
assay testing after the 2013 change in insecticide showed 
a loss of susceptibility to deltamethrin in local vectors. 
In standard WHO bioassays, 100  % (N  =  100) of An. 
gambiae s.s. mosquitoes died within 24 h of exposure to 
bendiocarb in 2014 and 2015. However, mortality to del-
tamethrin was only 79.6 % (N = 240) and 29 % (N = 100) 
in 2014 and 2015 respectively (BIMCP, unpublished 
observations). In 2015, in response to the low mortality 
rate to deltamethrin, the BIMCP carried out a further 
metabolic resistance study in the mosquito population in 
Bioko Island in collaboration with the Liverpool School 
of Tropical Medicine. The results showed an up-regula-
tion of P450-metabolic resistance in the Bioko mosquito 
population, indicating the lower susceptibility of the 
mosquitoes to pyrethroid insecticides (Hemingway, per-
sonal communication).
The BIMCP has discontinued the use of deltamethrin 
for IRS and has reverted to two rounds of bendiocarb in 
2016. Resistance to bendiocarb in the mosquito popula-
tion in Bioko will be monitored, and a rotational insec-
ticide scheme with products that have different modes 
of action, as suggested by the WHO [9], is planned. In 
2014 and 2015 (after this trial), the BIMCP carried out an 
island-wide mass-distribution with LLINs. Another mass 
distribution is planned in 2018. Due to pyrethroid resist-
ance, the BIMCP is now only distributing Permanet 3.0 
nets (Vestergaard) which contains a synergist as well as 
deltamethrin, increasing its efficacy against pyrethroid 
resistant malaria vectors. Since distributions of LLINs 
will be more frequent than before, the BIMCP expects 
that LLIN coverage will remain high with these new 
efforts. Beginning in 2015, the BIMCP targeted just 30 % 
of all households on Bioko with IRS, selecting communi-
ties most at-risk of malaria to receive bendiocarb IRS.
Conclusions
The results of this trial are inconclusive by themselves, 
but they suggest that bendiocarb may offer more pro-
tection against malaria infection than deltamethrin on 
Bioko. This could explain the 2013 island wide rise in 
malaria prevalence which occurred after spraying was 
switched to deltamethrin. As local vectors remain fully 
susceptible to bendiocarb whilst there is evidence of 
phenotypic and metabolic resistance to pyrethroids, it is 
likely that deltamethrin is less effective than bendiocarb 
on Bioko.
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